Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Moxaverine

Generic Name: Moxaverine

Drug Type: Small Molecule

Chemical Formula: C_₂₀H_₂₁NO_₂

CAS Number: 10539-19-2

Unique Ingredient Identifier: P3P08Y1XJ4

Overview

Moxaverine has been investigated for the treatment of Retina, Ocular Physiology, and Regional Blood Flow.

Background

Moxaverine has been investigated for the treatment of Retina, Ocular Physiology, and Regional Blood Flow.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Randomized, Placebo-controlled Study Investigating the Effects of Moxaverine on Ocular Blood Flow After Oral Administration in Healthy Subjects

Phase 2

Completed

Posted: 2012/06/27

Sponsor:Medical University o...

ID:NCT01629680

Effects of Moxaverine and Placebo on Ocular Blood Flow

Phase 2

Completed

Posted: 2008/07/03

Sponsor:Medical University o...

ID:NCT00709423

An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects

Phase 2

Completed

Posted: 2008/07/03

Sponsor:Medical University o...

ID:NCT00709449

A Randomized, Double-Masked, Placebo-Controlled Two Cross Over Study Comparing the Effects of Moxaverine and Placebo on Ocular Blood Flow

Phase 2

Completed

Posted: 2007/12/07

Sponsor:Medical University o...

ID:NCT00569621

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy